News Announcement

Gujarat Themis Biosyn: Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ('Listing Regulations')

The Board of Directors at its meeting held today have inter alia transacted the following items ofbusinesses:a) Approved the Unaudited Financial Results for the quarter and nine months ended31st December 2025b) The Board on the recommendation of the Nomination & Remuneration Committee hasapproved the re-appointment of Ms. Kirandeep Madan (DIN: 00686547) as Non-ExecutiveWoman Independent Director of the Company c) Considering the functional requirements of the Company Mr. Bhavik Shah Chief FinancialOfficer is transitioning into a different role within the organization. Based on therecommendation of the Nomination & Remuneration Committee and in order to strengthenthe finance function the Board approved the appointment of Mr. Krupesh Patel as ChiefFinancial Officer & Key Managerial Personnel of the Company

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.